Encompass Health (EHC) Gains from Investment Securities (2009 - 2025)

Encompass Health has reported Gains from Investment Securities for 17 years, with the latest figure at -$8.1 million in Q4 2025.

• For the quarter ending Q4 2025, Gains from Investment Securities fell 113.16% year-over-year to -$8.1 million; the trailing twelve-month figure through Mar 2026 stood at -$18.2 million (down 130.85% YoY), and the FY2025 full-year result was $4.1 million, down 81.19% from the prior year.
• Gains from Investment Securities for Q4 2025 stood at -$8.1 million, up from -$14.3 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $48.6 million in Q2 2021, with the low at -$32.0 million in Q3 2021.
• Historically, Gains from Investment Securities has averaged $3.0 million across 5 years, with a median of -$350000.0 in 2022.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities jumped 956.52% — and 2024, when it tumbled 1141.67%.
• Encompass Health's Gains from Investment Securities stood at -$12.0 million in 2021, then surged by 104.17% to $500000.0 in 2022, then plunged by 1120.0% to -$5.1 million in 2023, then increased by 25.49% to -$3.8 million in 2024, then slumped by 113.16% to -$8.1 million in 2025.
• The last three Gains from Investment Securities figures came in at -$8.1 million (Q4 2025), -$14.3 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.